top of page
Browse by category
Search


20 years in the bariatric industry: Past reflections, present challenges and future perspectives
In this interview, Arno van der Veek, Managing Director of Bariatric Solutions International, looks back on his career, the importance of...


Perspectives on ring-augmented sleeve gastrectomy
Professor Jodok Fink, Chief Physician of General and Visceral Surgery at Emmendingen District Hospital, Emmendingen, Germany and...


Re-evaluating the gastric band
Despite a decline in popularity and doubts over its long-term effectiveness, there is still a place for laparoscopic gastric banding...


Ring-augmented procedures for revisions and conversions
The number of patients undergoing revision or conversion bariatric procedures has been reported to be as high as 28%(1), however numbers...


Waist circumference stronger risk marker than BMI for obesity-related cancer in men
Waist circumference (WC) is a stronger risk marker than BMI for developing obesity-related cancers in men, but not women, according to a...


UK biobank study reveals link between new-onset T2DM and some, but not all, obesity-related cancers
Research to be presented at this year’s European Congress on Obesity 2025 (Malaga, Spain) shows that a new diagnosis of type 2 diabetes...


Gastric bypass associated with a lower incidence of MACE vs. sleeve gastrectomy over an 11-year follow-up
Gastric bypass (GB) is associated with a lower incidence of major adverse cardiac events (MACE) compared to sleeve gastrectomy (SG) over...


SURMOUNT-5: Tirzepatide shows superior weight loss over semaglutide
Seventy-two week outcomes from the SURMOUNT-5 clinical trial have shown that tirzepatide (Zepbound) met the primary endpoint and all five...


Significantly reduced post-LSG GERD rates with the Titan SGS Stapler vs. multi-fire staplers
A retrospective analysis of clinical data associating the use of the Titan SGS Stapler with reduced rates of post-operative GERD...


GLP-1 drugs benefit children who are living with severe obesity
Children who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 agonist drugs...
Browse by tag






bottom of page

